E C Medical Newsletter
A monthly edition of the latest developments in medical technology and interpretations of medical research. If you have a topic that you would like to see covered,
or have comments on our articles, please Contact
Us. We love to hear from you!
Vol. 3, No. 11; December 2006: This month the topics include the relationship between heartburn drugs and hip fracture, hormone replacement therapy and breast cancer risk, and wine polyphenols and cardiovascular health.
Vol 3, No 10; November 2006: This month the focus is on new developments in diabetes. New products are being developed to preserve beta cell function. Statin drugs are beneficial in reducing cardiovascular events in diabetic patients. Ways to prevent or delay the onset of diabetes are discussed.
Vol. 3, No. 9; October 2006: This month the topics are screening for lung cancer, an update on cancer stem cells, and the relationship of adequate sleep to obesity.
Vol 3, No 8; September 2006: This month the focus is on cancer therapies: monoclonal antibodies and small-molecules, targeted therapies combined with chemotherapy, and restoring cell-death mechanisms.
Vol 3, No 7; August 2006:Topics this month include bone loss in cancer patients, new advances in understanding metastasis, and infection as a cause of obesity.
Vol 3, No 6; July 2006: Cardiovascular disease is the focus this month: Statin drugs and soy protein for prevention, and heart valve surgery.
Vol 3, No 5; June 2006: Topics this month include viruses in gene evolution, activating apoptosis in cancer cells, and glucosamine/chondroitin supplements for osterarthritis.
Vol 3, No 4; May 2006: The entire issue is devoted to the emerging technology of RNA interference. This process can aid in the treatment of diseases that are due to the aberrant functioning of certain genes.
Vol 3, No 3; March-April 2006: The entire issue is devoted to the development of cancer vaccines. Vaccines appear more promising for prevention of cancer, rather than treatment.
Vol 3, No 2; February 2006: Topics include resistance to anticancer drugs, cancer stem cells, and low-fat diets.
Vol 3, No 1; January 2006; The entire issue is devoted to angiogenesis in health and disease, with a brief discussion of lymphangiogenesis, a parallel process.
Vol 2, No 3; December 2005: Topics include apoptosis in health and disease, osteoporosis in men, and the use of low-dose aspirin to prevent heart attacks.
Vol 2, No 2; November 2005: Topics include the use of laboratory mice in cancer research, glycomics (the structure and function of body carbohydrates), and an update on pharmacogenomics.
Vol 2, No 1; October 2005: The first edition of our completely revised newsletter! Topics include detecting cancer with autoantibodies, pharmacogenetics, COX-2 inhibitors, and diet and cancer.
Earlier Volume 1 editions:
Volume 1, Number 1: Media Coverage of
Medicine – How Accurate is it ?
Volume 1, Number 2: Should C-Reactive
Protein be Used to Screen for Coronary Artery Disease?
Volume 1, Number 3:The Placebo
Effect
Volume 1, Number 4: Antibiotics
in Animal Feeds: A Human Health Hazard?
Volume 1, Number 5: Role of Heat Shock
Proteins in Heart Disease
|